EU to Disallow Illumina's Grail Purchase
Separately, the US Federal Trade Commission said it will appeal an administrative law judge's initial decision in an antitrust case that was favorable to Illumina.
Illumina Says Judge Issued Favorable Decision in FTC Challenge to Grail Acquisition
According to the firm, the judge "rejected the FTC's position that the deal would adversely affect competition" of multi-cancer early detection tests.
Top 10 Articles on GenomeWeb in 2021
The most-read stories in 2021 represents readers' vast interests in the variety of topics covered by GenomeWeb from COVID-19 tests to IPOs and legal battles.
Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case
Caris said it has already provided materials to Illumina and should not have to indulge a "fishing expedition for irrelevant, highly sensitive details."
The FTC claimed that Illumina can and will disadvantage Grail's rivals, but lawyers for the companies said the merger's benefits outweigh "speculative harms."